LATE BREAKING CLINICAL TRIALS | ENDOVASCULAR

Tuesday, March 11, 2025

8:00 AM - 9:00 AM ET

Moderator(s)

Navneet Sharma, MD

Assistant Professor
Cleveland Clinic Foundation

No relationships to disclose
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panelist(s)

Shadi Halabi, MD

Interventional Cardiologist
Powers Healthcare System

No relationships to disclose
Rohan J. Kalathiya, MD

Interventional Cardiologist - Assistant Professor of Medicine, Division of Cardiology
Johns Hopkins School of Medicine
Potomac, Maryland, United States

Disclosure(s): No financial relationships to disclose
Giorgio A. Medranda, MD

Structural Interventional Cardiologist
NYU Langone Hospital - Long Island
Glen Cove, New York, United States

No relationships to disclose
M. Reza Movahed, Prof.

Clinical Professor of Medicine
University of Arizona, Tucson and Phoenix
Tucson, Arizona, United States

No relationships to disclose
Rachel Rosovsky, MD, MPH

Associate Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.
On Topaz, FACC, FSCAI,FACP

Professor of Medicine ,Duke University School of Medicine.
Duke University School of Medicine/Charles George VAMC Charles George Veterans Affairs MC Charles George Veterans Affairs MC
Biltmore Lake, North Carolina, United States

Disclosure information not submitted.

Disclosure(s):

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Giorgio A. Medranda, MD: No financial relationships to disclose

Rachel Rosovsky, MD, MPH: Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)

Kenneth Rosenfield, MD, MHCDS: Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

On Topaz, FACC, FSCAI,FACP: Angiodynamics/Auryon: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)